Charles River Laboratories
676 hedge funds and large institutions have $19.3B invested in Charles River Laboratories in 2021 Q3 according to their latest regulatory filings, with 83 funds opening new positions, 238 increasing their positions, 256 reducing their positions, and 37 closing their positions.
124% more first-time investments, than exits
New positions opened: 83 | Existing positions closed: 37
33% more call options, than puts
Call options by funds: $128M | Put options by funds: $96.7M
25% more funds holding in top 10
Funds holding in top 10: 16 → 20 (+4)
10% more capital invested
Capital invested by funds: $17.6B → $19.3B (+$1.74B)
6% more funds holding
Funds holding: 638 → 676 (+38)
7% less repeat investments, than reductions
Existing positions increased: 238 | Existing positions reduced: 256
1.75% less ownership
Funds ownership: 94.66% → 92.91% (-1.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Melvin Capital Management
New York
|
+$156M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$110M |
| 3 |
ESCM
Echo Street Capital Management
New York
|
+$75.3M |
| 4 |
BlackRock
New York
|
+$63.4M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$62.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$242M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$72.5M |
| 3 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
-$58.4M |
| 4 |
TCM
TimesSquare Capital Management
New York
|
-$51.7M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$47.7M |
CRL Hedge Fund Activity: Q3 2021 in Review
676 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q3 2021, worth a combined $19.3B — up 9.9% from $17.6B a quarter earlier.
Buyers outnumbered sellers: 83 funds opened new CRL positions and 37 closed out — a net gain of 46 holders — while 238 added to existing stakes and 256 trimmed.
The largest buyer was Melvin Capital Management, opening a new position worth an estimated $156M. The largest seller was Ameriprise, cutting an estimated $242M.
- 676 institutional investors held Charles River Laboratories (CRL) as of Q3 2021, up from 638 in Q2 2021.
- Funds reported $19.3B of Charles River Laboratories stock for Q3 2021, up 9.9% quarter-over-quarter.
- 83 funds opened new Charles River Laboratories positions in Q3 2021 and 37 closed out, a net change of +46 holders.
- The largest Charles River Laboratories buyer in Q3 2021 was Melvin Capital Management, an estimated $156M added.
- The largest Charles River Laboratories seller in Q3 2021 was Ameriprise, an estimated $242M sold.
Based on aggregated 13F filings for Q3 2021.